Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
Thomas Maddox, MD, explains some of the new, innovative technologies people should watch for in cardiology. He said some of these may define how cardiologist practice medicine in the next couple years.

Remote monitoring, AI to play key roles in the future of cardiology

Serious changes could be coming to a cardiology practice near you.

ASE President Ted Abraham, MD, speaking at the ASE HCM forum in 2023. Photo by Dave Fornell

Cardiologist begins term as American Society of Echocardiography's new president

Cardiologist Theodore Abraham, MD, has been an ASE member for more than two decades. He is now the organization's 2024-2025 president. 

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella use may not improve high-risk PCI outcomes

Impella heart pumps may not provide as much value when treating high-risk patients as early data suggested.

Biolimus A9 Coated Balloon from BioAscend

In-stent restenosis after PCI: New biolimus-coated balloon non-inferior to paclitaxel devices

A new study of nearly 300 PCI patients suggests biolimus-coated balloons could provide significant value to interventional cardiologists in the years ahead.  

pharmaceutical drug approval process

Biden Administration lowers prices for 64 prescription drugs, including 3 prescribed by cardiologists

The new list of discounted drugs includes an anticoagulant, a beta-blocker used to treat atrial fibrillation and much more. 

artificial intelligence AI heart cardiology

FDA clears new AI algorithm for 1-year AFib risk

The new algorithm from Tempus AI evaluates 12-lead ECG results, alerting users when a patient could be at risk of experiencing AFib within the next 12 months.

AliveCor, a California-based healthcare company focused on developing on-the-go electrocardiography (ECG) devices, has gained U.S. Food and Drug Administration (FDA) clearance for its KAI 12L artificial intelligence (AI) technology and the new handheld Kardia 12L ECG System.

Dual approvals: AliveCor gains FDA clearance for advanced AI model, handheld ECG system

One of the company's new approvals was for a pocket-sized ECG system designed to be less invasive and easier to use than other devices on the market. 

doctor with overweight patient who may be treated with TAVR or surgery

How persistent AFib impacts TAVR survival

Persistent and paroxysmal atrial fibrillation appear to affect short- and long-term TAVR mortality rates in different ways, according to a new study of nearly 3,000 patients. Some trends fade over time, while others remain in place after many years. 

Displaying 169 - 176 of 1685
Design by Adaptive Theme